Biomarker Identification through Proteomics in Colorectal Cancer
Colorectal cancer (CRC) is a devastating disease that ranks third in diagnosis and as the second leading cause of cancer-related deaths. The early detection of CRC has been shown to be the most effective strategy to improve treatment outcomes and patient survival. Therefore, current lines of researc...
Main Authors: | Desirée Martín-García, Marilina García-Aranda, Maximino Redondo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/4/2283 |
Similar Items
-
Clusterin Expression in Colorectal Carcinomas
by: Teresa Téllez, et al.
Published: (2023-09-01) -
Targeting Receptor Kinases in Colorectal Cancer
by: Marilina García-Aranda, et al.
Published: (2019-03-01) -
Immunotherapy: A Challenge of Breast Cancer Treatment
by: Marilina García-Aranda, et al.
Published: (2019-11-01) -
Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome
by: Jing Sun, et al.
Published: (2023-09-01) -
Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective
by: Alberto Puccini, et al.
Published: (2022-10-01)